BGLC

$2.50+0.25 (+10.92%)

Market OpenAs of Mar 17, 6:54 PM UTC

BioNexus Gene Lab Corp., through its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$2.50
Potential Upside
5%
Whystock Fair Value$2.62
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorBasic Materials
IndustrySpecialty Chemicals

BioNexus Gene Lab Corp., through its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other c...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$5.91M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.28
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-28.35%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
6.81

Recent News